Chapter 4: Psychopharmacology Flashcards
Psychopharmacology
Study of effects of drugs on nervous system and behavior
Drugs
Exogenous chemical not necessary for normal cellular functioning that significantly alters functions of certain cells of body when taken in relative low doses
Drug Effects
Observable changes in individual’s physiology and/ or behavior
Sites of Action
Location where drug molecules interact with molecules on or in cells to affect biochemical processes
Absorption
Drug is administered and absorbed through tissue
Distribution
Drug is distributed throughout blood and body
- Rate at which drug reaches sites of action is based on lipid solubility
Lipid Solubility
Ability of fat-based molecules to pass through cell membranes
Ex. Heroin is more lipid- soluble than morphine
Metabolism
Drug is changed to inactive form by enzymes (usually in liver)
Excretion
Drug is excreted in urine by kidneys
Intravenous (IV) Injection
Injection of substance directly into brain
Intraperitoneal (IP) Injection
Injection of substance into peritoneal cavity
Intramuscular (IM) Injection
Injection of substance into muscle
Subcutaneous (SC) Injection
Injection of substance into space beneath skin
Oral Administration
Administration of substance into mouth so that it is swallowed
Sublingual Administration
Administration of substance by placing in beneath tongue
Inhalation
Administration of vaporous substance into lungs
Topical Administration
Administration of substance directly onto skin or mucous membrane
Insufflation
Administration of substance by sniffing or snorting
- drug is absorbed through mucous membranes of nose
Dose Response Curve
Graph of magnitude of effect of drug as function of amount of drug administered
Therapeutic Index
Ratio between dose that produces desired effects in 50% of animals and dose that produces toxic effects in 50% of animals
Drugs vary in effectiveness because of:
- site of action
- affinity of drug with site of action
Drug Affinity
Readiness with which two molecules join together
- most desirable drug has high affinity for sites of action producing therapeutic effects and low affinity for sites of action producing toxic side effects
Opiates have more than one effect
- Analgesia
- Depress heart rate and respiration
Tolerance
Decrease in effectiveness of drug that is administered repeatedly
Sensitization
Increase in effectiveness of drug that is administered repeatedly
Withdrawal Symptom
Appearance of symptoms opposite to those produced by drugs when drug is administered repeatedly and then suddenly no longer taken
Physical Dependence
Compensatory changes following repeated use of drug that results in withdrawal symptoms when drug is no longer taken
Compensatory mechanisms that come with repeated drug use:
Decrease in effectiveness of binding
- Receptors become less sensitive - Receptor downregulation
Coupling process between receptors to ion channels or production of 2nd messengers is less effective
Receptor Downregulation
Decreased number of receptors
Placebo Effects
An inert substance that is given to organism instead of psychologically active drug
- used experimentally to control for effects of mere administration of drug
Antagonist
Drug that opposes/ inhibits effects of particular NT on postsynaptic cell
- drug inactivates enzymes used to synthesize NTs
Agonist
Drug that facilitates effects of particular NT on postsynaptic cell
- rate of synthesis and release of NT increases when precursor is administered
Antagonist Effects on Storage and Release of NTs
- Transporter molecules that fill synaptic vesicles are capable of being blocked by drugs
- Prevent release of NTs from termonal buttons
- Deactivate proteins that cause synaptic vesicles to fuse with presynaptic membrane
Direct Agonist
Drug that binds with and activates a receptor
Direct Antagonist
- Receptor blocker
- Drug that binds with receptor but doesn’t activate it
- Prevents natural ligand from binding with receptor
Noncompetitve Binding
Binding of drug to site on receptor
- Doesn’t interfere with binding site for principle ligand
Indirect Antagonist
Drug that attaches to binding site on receptor and interferes with action of receptor
- Doesn’t interfere with binding site for principal ligand
Indirect Agonist
Drug that attaches to binding site on receptor and facilitates action of receptor
- Doesn’t interfere with binding site for principal ligand
Agonist Effects on Reuptake or Destruction of NTs
- Molecules of drug attach to transporter molecules that are responsible for reuptake and inactivate them
- Molecules of drug bind with enzymes that normally deactivate NT and prevents enzymes from working
Glutamate
Most important excitatory NT in brain
- found in all neurons except pain neurons (produce substance P)
Vesicle Glutamate Transporter
Protein in vesicle membrane that pump Glu into vesicle
NMDA Receptor
Specialized ionotropic Glu-R that controls Ca2+ channel that is normally blocked by Mg2+ ions
- has several other binding sites (Glu and Gly co-agonists)